Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gm1078 Inhibitors

Gm1078 inhibitors are chemical compounds that specifically inhibit the activity of the Gm1078 protein, which is a member of a family of proteins involved in various cellular processes. These inhibitors act by binding to the active sites or other regulatory regions of Gm1078, disrupting its normal biochemical function. Structurally, Gm1078 inhibitors often contain molecular features that enable them to interact tightly with the protein's conformation, blocking its natural function. Such inhibitors can be designed based on the protein's three-dimensional structure, allowing for highly specific interactions. These inhibitors may vary widely in their chemical structure, ranging from small organic molecules to more complex structures with multiple functional groups that allow for strong binding affinity and selectivity. The design and synthesis of Gm1078 inhibitors can involve medicinal chemistry approaches that optimize their binding characteristics, stability, and overall structural properties.

The inhibitory mechanism of Gm1078 inhibitors typically involves interference with the protein's catalytic activity or its ability to interact with other molecular partners. By disrupting the normal function of Gm1078, these compounds can modulate the biochemical pathways in which the protein is involved. Biochemical studies often focus on identifying specific binding sites and understanding the structural requirements for inhibition, which can include hydrogen bonding, hydrophobic interactions, and van der Waals forces. Additionally, Gm1078 inhibitors may be characterized by their potency, which is quantified as the concentration required to achieve a certain level of inhibition (often represented as IC50 values). Structure-activity relationship (SAR) studies play a significant role in refining these inhibitors to achieve optimal interaction with the Gm1078 protein. Such inhibitors are valuable tools in research, as they help to elucidate the biological role of Gm1078 and its regulatory pathways in various cellular contexts.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can disrupt a wide range of kinases, possibly including SBK3.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

An isoflavone that acts as a tyrosine kinase inhibitor and may affect SBK3 activity.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

A specific inhibitor of protein kinase C that might also interfere with related kinases such as SBK3.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can indirectly affect kinase pathways, possibly impacting SBK3 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which can alter signaling pathways and potentially affect SBK3.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAP kinase inhibitor that could indirectly interfere with SBK3 signaling pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor that could disrupt upstream signaling affecting SBK3.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can influence the activity and signaling of kinases, possibly including SBK3.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

A broad-spectrum tyrosine kinase inhibitor that may indirectly inhibit SBK3 function.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A Raf kinase inhibitor that may disrupt signaling pathways involving SBK3.